These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 39122830)

  • 21. G-CSF upregulates the expression of aquaporin-9 through CEBPB to enhance the cytotoxic activity of arsenic trioxide to acute myeloid leukemia cells.
    Fu W; Zhu G; Xu L; Liu J; Han X; Wang J; Wang X; Hou J; Zhao H; Zhong H
    Cancer Cell Int; 2022 May; 22(1):195. PubMed ID: 35590355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biotransformation of arsenic trioxide by AS3MT favors eradication of acute promyelocytic leukemia: revealing the hidden facts.
    Maimaitiyiming Y; Zhu HH; Yang C; Naranmandura H
    Drug Metab Rev; 2020 Aug; 52(3):425-437. PubMed ID: 32677488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arsenic trioxide induces proteasome dependent TBLR1-RARα degradation to improve leukemia eradication through cell differentiation enhancement.
    Chen Y; Li M; Wu H; Yuan S; Xia Y; Wang Y; Peng Y; Lan J; Wang Y
    J Cancer; 2022; 13(7):2301-2311. PubMed ID: 35517404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Death-associated protein 5 (DAP5/p97/NAT1) contributes to retinoic acid-induced granulocytic differentiation and arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
    Ozpolat B; Akar U; Zorrilla-Calancha I; Vivas-Mejia P; Acevedo-Alvarez M; Lopez-Berestein G
    Apoptosis; 2008 Jul; 13(7):915-28. PubMed ID: 18491231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chloroquine aggravates the arsenic trioxide (As2O3)-induced apoptosis of acute promyelocytic leukemia NB4 cells via inhibiting lysosomal degradation in vitro.
    Liu DM; Zhang XD; Yang L
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6412-6421. PubMed ID: 30338810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenic trioxide cooperates with all trans retinoic acid to enhance mitogen-activated protein kinase activation and differentiation in PML-RARalpha negative human myeloblastic leukemia cells.
    Nayak S; Shen M; Bunaciu RP; Bloom SE; Varner JD; Yen A
    Leuk Lymphoma; 2010 Sep; 51(9):1734-47. PubMed ID: 20615082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-Myc Inhibition Using 10058-F4 Increased the Sensitivity of Acute Promyelocytic Leukemia Cells to Arsenic Trioxide Via Blunting PI3K/NF-κB Axis.
    Sayyadi M; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Abolghasemi H; Anoushirvani AA; Bashash D
    Arch Med Res; 2020 Oct; 51(7):636-644. PubMed ID: 32553459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arsenic trioxide in hematological malignancies: the new discovery of an ancient drug.
    Bonati A; Rizzoli V; Lunghi P
    Curr Pharm Biotechnol; 2006 Dec; 7(6):397-405. PubMed ID: 17168655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resource utilization and cost effectiveness of treating acute promyelocytic leukaemia using generic arsenic trioxide.
    Bankar A; Korula A; Kulkarni UP; Devasia AJ; Na F; Lionel S; Abraham A; Balasubramanian P; Janet NB; Nair SC; S S; Jeyaseelan V; N J; Prasad J; George B; Mathews V
    Br J Haematol; 2020 Apr; 189(2):269-278. PubMed ID: 31863602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
    Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
    Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute promyelocytic leukemia: state-of-the-art management].
    Asou N
    Rinsho Ketsueki; 2018; 59(6):725-734. PubMed ID: 29973452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sumoylation of the Tumor Suppressor Promyelocytic Leukemia Protein Regulates Arsenic Trioxide-Induced Collagen Synthesis in Osteoblasts.
    Xu WX; Liu SZ; Wu D; Qiao GF; Yan J
    Cell Physiol Biochem; 2015; 37(4):1581-91. PubMed ID: 26517826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adding ascorbic acid to arsenic trioxide produces limited benefit in patients with acute myeloid leukemia excluding acute promyelocytic leukemia.
    Aldoss I; Mark L; Vrona J; Ramezani L; Weitz I; Mohrbacher AM; Douer D
    Ann Hematol; 2014 Nov; 93(11):1839-43. PubMed ID: 24906216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells.
    Martelli MP; Gionfriddo I; Mezzasoma F; Milano F; Pierangeli S; Mulas F; Pacini R; Tabarrini A; Pettirossi V; Rossi R; Vetro C; Brunetti L; Sportoletti P; Tiacci E; Di Raimondo F; Falini B
    Blood; 2015 May; 125(22):3455-65. PubMed ID: 25795919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BIMEL is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine.
    Tanaka Y; Komatsu T; Shigemi H; Yamauchi T; Fujii Y
    BMC Cancer; 2014 Jan; 14():27. PubMed ID: 24428916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arsenic induced epigenetic changes and relevance to treatment of acute promyelocytic leukemia and beyond.
    Maimaitiyiming Y; Wang QQ; Hsu CH; Naranmandura H
    Toxicol Appl Pharmacol; 2020 Nov; 406():115212. PubMed ID: 32882258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Synergistic lethal effect of combined treatment of arsenic trioxide and aclacinomycin on human acute myeloid leukemia cell line KG-1a].
    Ye YB; Xu XJ; Chen YH; Zhang MW; Qiu DF; Guo ZW; He HQ
    Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):256-262. PubMed ID: 28550664
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of Dihydroartemisinin and Arsenic Trioxide on Apoptosis of Acute Myeloid Leukemia Cells].
    Sun WD; Wang X; Wang Y; Tong XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1337-1342. PubMed ID: 36208232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of proteasome induces apoptosis in APL cells and increases chemo-sensitivity to arsenic trioxide: Proposing a perception in APL treatment.
    Zamani-Moghaddam N; Mousavi FS; Esmaeili S; Yousefi AM; Safaroghli-Azar A; Bashash D
    Cancer Treat Res Commun; 2021; 26():100284. PubMed ID: 33387871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic strategy of arsenic trioxide in the fight against cancers and other diseases.
    Wang QQ; Jiang Y; Naranmandura H
    Metallomics; 2020 Mar; 12(3):326-336. PubMed ID: 32163072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.